These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 25009224)

  • 21. Physical fitness, walking performance, and gait in multiple sclerosis.
    Sandroff BM; Sosnoff JJ; Motl RW
    J Neurol Sci; 2013 May; 328(1-2):70-6. PubMed ID: 23522499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T
    Louapre C; Govindarajan ST; Giannì C; Madigan N; Nielsen AS; Sloane JA; Kinkel RP; Mainero C
    Neuroimage Clin; 2016; 12():879-886. PubMed ID: 27872810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in the Russian Population.
    Evdoshenko E; Laskova K; Shumilina M; Nekrashevich E; Andreeva M; Neofidov N; Kalinin I; Nikitchenko D; Rogozina A; Kupaeva A; Bulanov I; Bakirtzis C; Grigoriadis N; Khachanova N; Davydovskaya M; Makshakov G
    J Int Neuropsychol Soc; 2022 May; 28(5):503-510. PubMed ID: 34132190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between processing speed and verbal and non-verbal new learning and memory in progressive multiple sclerosis.
    Chiaravalloti ND; DeLuca J; Salter A; Amato MP; Brichetto G; Chataway J; Dalgas U; Farrell R; Feys P; Filippi M; Freeman J; Inglese M; Meza C; Moore NB; Motl RW; Rocca MA; Sandroff BM; Cutter G; Feinstein A
    Mult Scler; 2022 Oct; 28(11):1783-1792. PubMed ID: 35531965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impairment and disability in persons with MS: do functional performance or functional limitations matter?
    Klaren RE; Pilutti LA; Sandroff BM; Motl RW
    Psychol Health Med; 2015; 20(6):646-52. PubMed ID: 25815752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimodal exercise training in multiple sclerosis: A randomized controlled trial in persons with substantial mobility disability.
    Sandroff BM; Bollaert RE; Pilutti LA; Peterson ML; Baynard T; Fernhall B; McAuley E; Motl RW
    Contemp Clin Trials; 2017 Oct; 61():39-47. PubMed ID: 28732757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive dysfunction and multiple sclerosis: developing a rationale for considering the efficacy of exercise training.
    Motl RW; Sandroff BM; Benedict RH
    Mult Scler; 2011 Sep; 17(9):1034-40. PubMed ID: 21685231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical activity, sedentary behavior, and aerobic capacity in persons with multiple sclerosis.
    Motl RW; Sandroff BM; Pilutti LA; Klaren RE; Baynard T; Fernhall B
    J Neurol Sci; 2017 Jan; 372():342-346. PubMed ID: 28017242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No association between body composition and cognition in ambulatory persons with multiple sclerosis: A brief report.
    Sandroff BM; Hubbard EA; Pilutti LA; Motl RW
    J Rehabil Res Dev; 2015; 52(3):301-8. PubMed ID: 26230584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers.
    Fenu G; Fronza M; Lorefice L; Arru M; Coghe G; Frau J; Marrosu MG; Cocco E
    BMC Neurol; 2018 Dec; 18(1):212. PubMed ID: 30567519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the criterion validity of four highly abbreviated measures from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
    Gromisch ES; Zemon V; Holtzer R; Chiaravalloti ND; DeLuca J; Beier M; Farrell E; Snyder S; Schairer LC; Glukhovsky L; Botvinick J; Sloan J; Picone MA; Kim S; Foley FW
    Clin Neuropsychol; 2016 Oct; 30(7):1032-49. PubMed ID: 27279357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute effects of walking, cycling, and yoga exercise on cognition in persons with relapsing-remitting multiple sclerosis without impaired cognitive processing speed.
    Sandroff BM; Hillman CH; Benedict RH; Motl RW
    J Clin Exp Neuropsychol; 2015; 37(2):209-19. PubMed ID: 25658772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
    Motl RW; Cadavid D; Sandroff BM; Pilutti LA; Pula JH; Benedict RH
    J Neurol Sci; 2013 Dec; 335(1-2):169-73. PubMed ID: 24104065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality and quantity of diffuse and focal white matter disease and cognitive disability of patients with multiple sclerosis.
    Bomboi G; Ikonomidou VN; Pellegrini S; Stern SK; Gallo A; Auh S; Evangelou IE; Agarwal J; Pellicano C; Ohayon JM; Cantor FK; Ehrmantraut M; McFarland HF; Kane RL; Bagnato F
    J Neuroimaging; 2011 Apr; 21(2):e57-63. PubMed ID: 20626570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive decline in Multiple Sclerosis patients.
    Koutsouraki E; Kalatha T; Grosi E; Koukoulidis T; Michmizos D
    Hell J Nucl Med; 2019; 22 Suppl():75-81. PubMed ID: 30877725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trial.
    Briken S; Gold SM; Patra S; Vettorazzi E; Harbs D; Tallner A; Ketels G; Schulz KH; Heesen C
    Mult Scler; 2014 Mar; 20(3):382-90. PubMed ID: 24158978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low serum 25‑hydroxy-vitamin D levels are associated with cognitive impairment in multiple sclerosis.
    Spiezia AL; Falco F; Manganelli A; Carotenuto A; Petracca M; Novarella F; Iacovazzo C; Servillo G; Lanzillo R; Brescia Morra V; Moccia M
    Mult Scler Relat Disord; 2023 Nov; 79():105044. PubMed ID: 37837668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olfactory function and cognition in relapsing-remitting and secondary-progressive multiple sclerosis.
    Carotenuto A; Costabile T; Moccia M; Falco F; Scala MR; Russo CV; Saccà F; De Rosa A; Lanzillo R; Brescia Morra V
    Mult Scler Relat Disord; 2019 Jan; 27():1-6. PubMed ID: 30273697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial effects of a nano formulation of pomegranate seed oil, GranaGard, on the cognitive function of multiple sclerosis patients.
    Petrou P; Ginzberg A; Binyamin O; Karussis D
    Mult Scler Relat Disord; 2021 Sep; 54():103103. PubMed ID: 34243101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel cognitive-behavioral stress management method for multiple sclerosis. A brief report of an observational study.
    Anagnostouli M; Babili I; Chrousos G; Artemiadis A; Darviri C
    Neurol Res; 2019 Mar; 41(3):223-226. PubMed ID: 30451648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.